List of works - Stephanie Filleur

A randomized study of docetaxel and dexamethasone with low- or high-dose estramustine for patients with advanced hormone-refractory prostate cancer

scientific article published on 01 September 2006

AFM nano-mechanics and calcium dynamics of prostate cancer cells with distinct metastatic potential ⬇️

scientific article published on February 16, 2012

Androgen receptor targets NFkappaB and TSP1 to suppress prostate tumor growth in vivo.

scientific article

Androgens repress the expression of the angiogenesis inhibitor thrombospondin-1 in normal and neoplastic prostate

scientific journal article

Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats.

scientific article published in November 2002

Cabazitaxel regimens inhibit the growth of prostate cancer cells and enhances the anti-tumor properties of PEDF with various efficacy and toxicity

scientific article published on 10 May 2018

Characterization of PEDF: a multi-functional serpin family protein

scientific article

Characterization of prognostic factors and efficacy in a phase-II study with docetaxel and estramustine for advanced hormone refractory prostate cancer.

scientific article published in November 2005

Clinical outcome of patients with docetaxel-resistant hormone-refractory prostate cancer treated with second-line cyclophosphamide-based metronomic chemotherapy.

scientific article

Evaluation of peri-operative peripheral and renal venous levels of pro- and anti-angiogenic factors and their relevance in patients with renal cell carcinoma

scientific article published on 08 April 2007

Extraluminal colonic carcinoma invading into kidney: a case report and review of the literature

scientific article

Human breast tumors override the antiangiogenic effect of stromal thrombospondin-1 in vivo

scientific article published on 01 September 2005

Idiopathic retroperitoneal fibrosis (Ormond's disease)

scientific article

Impact of PSA flare-up in patients with hormone-refractory prostate cancer undergoing chemotherapy.

scientific article

In vivo upregulation of CD95 and CD95L causes synergistic inhibition of angiogenesis by TSP1 peptide and metronomic doxorubicin treatment.

scientific article published in June 2005

Leiomyosarcoma of the urinary bladder presenting as life threatening gross hematuria.

scientific article published on 11 June 2009

Nuclear factor of activated T cells balances angiogenesis activation and inhibition.

scientific article

Oral/metronomic cyclophosphamide-based chemotherapy as option for patients with castration-refractory prostate cancer: review of the literature.

scientific article published on 28 January 2011

PEDF increases the tumoricidal activity of macrophages towards prostate cancer cells in vitro

scientific article

PEDF inhibits IL8 production in prostate cancer cells through PEDF receptor/phospholipase A2 and regulation of NFκB and PPARγ ⬇️

scientific article published on May 13, 2011

Pigment epithelium-derived factor and interleukin-6 control prostate neuroendocrine differentiation via feed-forward mechanism.

scientific article

Pigment epithelium-derived factor expression prolongs survival and enhances the cytotoxicity of low-dose chemotherapy in castration-refractory prostate cancer.

scientific article

Positive correlation between PEDF expression levels and macrophage density in the human prostate

scientific article

TFE3 Translocation-Associated Renal Cell Carcinoma Presenting as Avascular Necrosis of the Femur in a 19-Year-Old Patient: Case Report and Review of the Literature

scientific article

The Wnt non-canonical signaling modulates cabazitaxel sensitivity in prostate cancer cells

scientific article published on 02 June 2020

The clinical usefulness of nuclear matrix protein-22 in patients with end-stage renal disease and microscopic hematuria

scientific article published on 14 November 2012

Two functional epitopes of pigment epithelial-derived factor block angiogenesis and induce differentiation in prostate cancer

scientific article

Vacuolar H+-ATPase is down-regulated by the angiogenesis-inhibitory pigment epithelium-derived factor in metastatic prostate cancer cells

scientific article

[Self-inflicted penile strangulation]

scientific article published on 06 November 2009

List of works by Stephanie Filleur

A randomized study of docetaxel and dexamethasone with low- or high-dose estramustine for patients with advanced hormone-refractory prostate cancer

AFM nano-mechanics and calcium dynamics of prostate cancer cells with distinct metastatic potential ⬇️

Androgen receptor targets NFkappaB and TSP1 to suppress prostate tumor growth in vivo.

Androgens repress the expression of the angiogenesis inhibitor thrombospondin-1 in normal and neoplastic prostate

Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats.

Cabazitaxel regimens inhibit the growth of prostate cancer cells and enhances the anti-tumor properties of PEDF with various efficacy and toxicity

Characterization of PEDF: a multi-functional serpin family protein

Characterization of prognostic factors and efficacy in a phase-II study with docetaxel and estramustine for advanced hormone refractory prostate cancer.

Clinical outcome of patients with docetaxel-resistant hormone-refractory prostate cancer treated with second-line cyclophosphamide-based metronomic chemotherapy.

Evaluation of peri-operative peripheral and renal venous levels of pro- and anti-angiogenic factors and their relevance in patients with renal cell carcinoma

Extraluminal colonic carcinoma invading into kidney: a case report and review of the literature

Human breast tumors override the antiangiogenic effect of stromal thrombospondin-1 in vivo

Idiopathic retroperitoneal fibrosis (Ormond's disease)

Impact of PSA flare-up in patients with hormone-refractory prostate cancer undergoing chemotherapy.

In vivo upregulation of CD95 and CD95L causes synergistic inhibition of angiogenesis by TSP1 peptide and metronomic doxorubicin treatment.

Leiomyosarcoma of the urinary bladder presenting as life threatening gross hematuria.

Nuclear factor of activated T cells balances angiogenesis activation and inhibition.

Oral/metronomic cyclophosphamide-based chemotherapy as option for patients with castration-refractory prostate cancer: review of the literature.

PEDF increases the tumoricidal activity of macrophages towards prostate cancer cells in vitro

PEDF inhibits IL8 production in prostate cancer cells through PEDF receptor/phospholipase A2 and regulation of NFκB and PPARγ ⬇️

Pigment epithelium-derived factor and interleukin-6 control prostate neuroendocrine differentiation via feed-forward mechanism.

Pigment epithelium-derived factor expression prolongs survival and enhances the cytotoxicity of low-dose chemotherapy in castration-refractory prostate cancer.

Positive correlation between PEDF expression levels and macrophage density in the human prostate

TFE3 Translocation-Associated Renal Cell Carcinoma Presenting as Avascular Necrosis of the Femur in a 19-Year-Old Patient: Case Report and Review of the Literature

The Wnt non-canonical signaling modulates cabazitaxel sensitivity in prostate cancer cells

The clinical usefulness of nuclear matrix protein-22 in patients with end-stage renal disease and microscopic hematuria

Two functional epitopes of pigment epithelial-derived factor block angiogenesis and induce differentiation in prostate cancer

Vacuolar H+-ATPase is down-regulated by the angiogenesis-inhibitory pigment epithelium-derived factor in metastatic prostate cancer cells

[Self-inflicted penile strangulation]